9 February 2017 - Bupa is calling on the Turnbull government to further reform medical device prices as the health insurance giant pushes for greater transparency to force prices lower.
Private health insurers have long called for cuts to prices on the Prostheses List, which sets how much funds pay for devices, but were disappointed last year when the government announced $86 million worth of cuts: they were targeting $800m.
Richard Bowden, Bupa’s Australia/New Zealand managing director, who recently took the top job after a stint at its British arm, said the price difference between Britain and Australia for some devices was “indefensible”.